Literature DB >> 3176875

EEG in demented and non-demented parkinsonian patients.

M Y Neufeld1, R Inzelberg, A D Korczyn.   

Abstract

The electroencephalograms (EEG) of patients with Parkinson's disease (PD) were evaluated in relation to age, mental status and motor disability. Abnormalities, particularly mild slowing, were observed in 34% of 128 patients and more frequently in the elderly. While a slowing in occipital background activity was more frequent in demented patients, a statistically significant association was also observed between the degree of motor disability and the frequency of slowing in occipital background activity in mentally intact patients. This correlation may suggest that subcortical structures (involved in motor control) influence occipital background activity.

Entities:  

Mesh:

Year:  1988        PMID: 3176875     DOI: 10.1111/j.1600-0404.1988.tb03609.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

Authors:  B T Klassen; J G Hentz; H A Shill; E Driver-Dunckley; V G H Evidente; M N Sabbagh; C H Adler; J N Caviness
Journal:  Neurology       Date:  2011-06-01       Impact factor: 9.910

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

3.  Non-linear dynamical analysis of multichannel EEG: clinical applications in dementia and Parkinson's disease.

Authors:  K J Stam; D L Tavy; B Jelles; H A Achtereekte; J P Slaets; R W Keunen
Journal:  Brain Topogr       Date:  1994       Impact factor: 3.020

4.  EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review.

Authors:  Chelsie N Poffenberger; Sara Inati; Nahid Tayebi; Barbara K Stubblefield; Emory Ryan; Raphael Schiffmann; Ellen Sidransky; Grisel Lopez
Journal:  Mol Genet Metab       Date:  2020-10-20       Impact factor: 4.797

5.  Investigation of EEG abnormalities in the early stage of Parkinson's disease.

Authors:  Chun-Xiao Han; Jiang Wang; Guo-Sheng Yi; Yan-Qiu Che
Journal:  Cogn Neurodyn       Date:  2013-02-10       Impact factor: 5.082

6.  Inter-hemispheric EEG coherence analysis in Parkinson's disease: assessing brain activity during emotion processing.

Authors:  R Yuvaraj; M Murugappan; Norlinah Mohamed Ibrahim; Kenneth Sundaraj; Mohd Iqbal Omar; Khairiyah Mohamad; R Palaniappan; M Satiyan
Journal:  J Neural Transm (Vienna)       Date:  2014-06-04       Impact factor: 3.575

7.  A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming.

Authors:  M M Ponsen; C J Stam; J L W Bosboom; H W Berendse; A Hillebrand
Journal:  Neuroimage Clin       Date:  2012-11-17       Impact factor: 4.881

8.  On the analysis of EEG power, frequency and asymmetry in Parkinson's disease during emotion processing.

Authors:  Rajamanickam Yuvaraj; Murugappan Murugappan; Norlinah Mohamed Ibrahim; Mohd Iqbal; Kenneth Sundaraj; Khairiyah Mohamad; Ramaswamy Palaniappan; Edgar Mesquita; Marimuthu Satiyan
Journal:  Behav Brain Funct       Date:  2014-04-09       Impact factor: 3.759

9.  Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.

Authors:  A Gulberti; C K E Moll; W Hamel; C Buhmann; J A Koeppen; K Boelmans; S Zittel; C Gerloff; M Westphal; T R Schneider; A K Engel
Journal:  Neuroimage Clin       Date:  2015-09-25       Impact factor: 4.881

10.  Non-linear dynamical analysis of EEG time series distinguishes patients with Parkinson's disease from healthy individuals.

Authors:  Claudia Lainscsek; Manuel E Hernandez; Jonathan Weyhenmeyer; Terrence J Sejnowski; Howard Poizner
Journal:  Front Neurol       Date:  2013-12-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.